The Cuban government reaffirmed today its commitment to continue working for the well-being and health of its people. Despite unprecedented hostility from the United States. In this regard, Bruno Rodríguez Parrilla, Cuba’s Minister of Foreign Affairs, highlighted the reactivation of production of 16 cytostatic drugs. For the National Cancer Patient Care Program as an example of this effort.
This comes, the Foreign Minister noted via social media, after a significant investment process. Carried out “amid severe economic limitations caused by the extreme intensification of the blockade and an unprecedented energy embargo.”
Rodríguez emphasized the significance of these medications, produced by the AICA Laboratories Company. Part of the Biotechnology and Pharmaceutical Industries Group (Biocubafarma). Stressing that “each drug produced at this plant represents sovereignty, hope, and a commitment to the right to health for all Cubans.”
Previously, following last week’s announcement of the reactivation of this plant. Cuban President Miguel Díaz-Canel referred to the event in similar terms, calling it great news.
The reactivation of production of 16 cytostatic drugs for the National Program for the Care of Cancer Patients is not an isolated event. It is a clear example of how the Cuban biotechnology industry and the Public Health System work in full partnership. Also to ensure the availability of essential medicines at the most critical time.
With information from Prensa Latina
- Iran Denounces Recent US Attacks as Violation of International Law - 10 de June de 2026
- Civil Phase Completed for Holguin’s First Solar Charging Station - 10 de June de 2026
- Etecsa’s Digital Tool Boosts Connectivity and Business Management in Holguin - 10 de June de 2026